2009 | 2008 | 2007 | 2006 | 2005 |  2004 | 2003 |  2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | AllPubMed

Publications - 2007

Vlodavsky I, Ilan N, Nadir Y, Brenner B, Katz BZ, Naggi A, Torri G, Casu B, Sasisekharan R.
Heparanase, heparin and the coagulation system in cancer progression. Thromb Res. 2007;120 Suppl 2:S112-20.

Raman R, Sasisekharan R. Cooperativity in Glycan-Protein Interactions. Chem Biol. 2007 Aug 24; 14(8):873-874.

Guerrini M, Guglieri S, Naggi A, Sasisekharan R, Torri G. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost. 2007 Jul; 33(5):478-87.

Yang Y, Macleod V, Dai Y, Khotskaya-Sample Y, Shriver Z, Venkataraman G, Sasisekharan R, Naggi A, Torri G, Casu B, Vlodavsky I, Suva LJ, Epstein J, Yaccoby S, Shaughnessy JD Jr, Barlogie B, Sanderson RD. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood. 2007 May 29

Sengupta S and Sasisekharan R. Exploiting nanotechnology to target cancer. Brit Jour Cancer 2007 May 7;96(9):1315-9. [Epub 2007 Apr 3]

Last Updated: February 4, 2008